Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Wu JJ
  • MESH
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Interleukin-17
  • Male
  • Psoriasis
  • Receptors, Interleukin-17

Unbound MEDLINE

Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis.

Links

  • Publisher Full Text

    • Authors

    Wu JJ

    Source

    The New England journal of medicine 367:3 2012 Jul 19 pg 274-5; author reply 275

    MeSH

    Antibodies, Monoclonal
    Antibodies, Monoclonal, Humanized
    Female
    Humans
    Interleukin-17
    Male
    Psoriasis
    Receptors, Interleukin-17

    Pub Type(s)

    Comment
    Letter

    Language

    eng

    PubMed ID

    22808967

    Related Citations

    • Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis.
    • To be 17 again--anti-interleukin-17 treatment for psoriasis.
    • Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.
    • [Monoclonal antibodies targeting IL-17A or its receptor in psoriasis: a new therapeutic approach?].
    • New biologic drugs get under the skin of psoriasis.
    • Anti-IL-17 mAbs herald new options in psoriasis.
    • Erythrodermic psoriasis improved by panitumumab, but not bevacizumab.
    • Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved